TOP TIERMARKET NEWSWIRE
News & sentiment

MADRIGAL PHARMACEUTI (MDGL) — News & AI sentiment

MADRIGAL PHARMACEUTI (MDGL) news roundup. 3 stories in the past week, 7 over 30 days. Average 30-day sentiment is 56.4/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $7.9M — net selling of $7.9M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 60.7/100
30d stories
7
avg sentiment 56.4/100
Insider net (90d)
$7.9M
0 buys · 3 sells
Congress (90d)
0
0 buys · 0 sells

MDGL news in the last 24 hours, 7 days, 30 days and 90 days

How much MDGL coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowMDGL storiesAvg AI sentimentRead
Last 24 hours0no coverage
Last 7 days360.7/100MDGL headlines →
Last 30 days756.4/100MDGL headlines →
Last 90 days3656.4/100MDGL headlines →

Latest stories on MDGL

3d ago
3d ago
3d ago
Sep 2
Aug 25
Aug 20
Aug 20
Aug 12
Aug 12
Aug 12
Aug 11
Aug 6
Aug 6
Aug 5
Wolfe Research upgrades Madrigal Pharmaceuticals stock rating on Q2 beat
Investing.com Analyst Ratings63 · neutralanalyst
Aug 4
Jul 31
H.C. Wainwright reiterates Madrigal Pharmaceuticals stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Jul 31
Barclays lowers Madrigal Pharmaceuticals stock price target to $962
Investing.com Analyst Ratings34 · bearishanalyst
Jul 31
Jul 30
Jul 30
Jul 30
Jul 30
Jul 30
Jul 30
Jul 30
Open MDGL in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →